Status:
UNKNOWN
Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
AstraZeneca
Conditions:
Drug Contamination
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to verify the existence of bacterial and/or fungal contamination during different technics of propofol with or without EDTA continuous infusion in patients undergoing gene...
Eligibility Criteria
Inclusion
- Age eighteen years old or more
- ASA Physiological Status P1 ou P2
- Patients undergoing clean procedure under general anesthesia.
Exclusion
- Patients under eighteen years old
- ASA Physiological Status P3, P4 or P5
- Current infectious process
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
652 Patients enrolled
Trial Details
Trial ID
NCT00757458
Start Date
December 1 2008
End Date
December 1 2009
Last Update
September 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade de Sao Paulo Hospital das Clinicas
São Paulo, São Paulo, Brazil, 05403-000